D
DaVita Clinical Research | Stone Oak, San Antonio, TX
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
AP306
Clazakizumab
KBP-5074
BI 685509
Parent organization
This site is a part of DaVita Clinical Research
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 5 total trials
Locations recently updated
This study is being conducted to characterize the safety, tolerability, and efficacy of AP306 at fixed doses in adults with hyperphosphatemia receivi...
Begins enrollment this month
End Stage Renal Disease on Dialysis
Chronic Kidney Disease Requiring Chronic Dialysis
Drug: AP306 75 mg TID
Drug: AP306 150 mg BID
This is a 2-part (phase 2b/3) prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1 (phase 2b) is a do...
Enrolling
Atherosclerotic Cardiovascular Disease
Atherosclerotic Cardiovascular Disease in Patients With ESKD
Drug: Placebo
Drug: CSL300
Trial sponsors
K
R
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems